The global epinephrine market size is expected to reach USD 4.76 Billion by 2028 at a CAGR of 8.7%, according to the latest report by Reports and Data. Increasing demand for auto-injectors owing to their quick administration during emergency situations, increasing incidence of severe allergic reactions and anaphylactic shock, and technological advancements in epinephrine injectors are key factors expected to drive market revenue growth over the forecast period. Epinephrine is widely used to restore cardiac rhythm, control asthma, and treat life-threatening allergic reactions. This is also a key factor boosting demand for epinephrine products and is expected to contribute to market growth going ahead.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@https://www.reportsanddata.com/sample-enquiry-form/91
Epinephrine, or adrenaline, is a hormone and neurotransmitter having vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. Epinephrine is one of the most widely used agents as it can function both as a medication and hormone. Epinephrine has been approved by the FDA for the treatment of type 1 hypersensitivity reaction, cardiac arrest, and asthma attacks and also has several off-label uses. Epinephrine plays an important role in fight-or-flight response by increasing blood flow to muscles. Based on the diagnosis, epinephrine administration varies such as it can be given intravenously, injection into muscles, by inhalation, or by injecting just under the skin.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.reportsanddata.com/report-detail/epinephrine-market
Some Key Highlights from the Report:
- Epinephrine auto-injector segment is expected to register significant revenue growth over the forecast period owing to growing demand for prefilled auto-injectors due to its quick response, launch of affordable generic epinephrine products, and innovations in auto-injectors.
- Anaphylaxis segment is expected to account for a significant share in the global market owing to increasing incidence of anaphylactic allergic reactions and increasing number of people susceptible to allergies. Epinephrine is primary treatment approach for anaphylaxis.
- North America is expected to account for largest revenue share in the global market owing to increasing number of people with life-threatening food allergies, rise in chronic illnesses due to allergies, presence of robust healthcare facilities, and rapid launch of advanced epinephrine injections and products.
- Key companies in the market include Abbott Laboratories, Lincoln Medical, Ltd., Mylan, Inc., Sanofi SA, Amedra Pharmaceuticals LLC and ALK Abello A/S.
- In June 2021, Alerje Inc., which is a food allergy management company based in Detroit, introduced a smartphone case equipped with auto-injector that rapidly releases epinephrine during severe allergic reactions. It will also automatically alter the patients’ support circle through Alerje smartphone app when a dose is discharged from the case.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/91
For the purpose of this report, Reports and Data has segmented the global epinephrine market on the basis of type, application, and region:
Type Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)
- Epinephrine Auto-injector
- Epinephrine Prefilled Syringe
- Others
Application Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)
- Anaphylaxis
- Others
Regional Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of APAC
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of Latin America
- Middle East Africa
- U.A.E.
- Saudi Arabia
- South Africa
- Rest of MEA
Growing advancements in medical therapies to drive market growth
The pharmaceutical and healthcare industry is driven by rapid advancements in customized therapies, medical devices, and surgical procedures. Integration of advanced technologies to accelerate research and development and manufacturing and production activities are some other factors driving market growth.
High prices of certain drugs might affect revenue growth
Launch of high-priced drugs to treat rare and chronic diseases and lesser affordability in middle- and low-income regions might limit their adoption and restrain market growth going ahead. In addition, less knowledge and awareness regarding advanced treatment approaches and lower adoption of advanced technologies might further hamper market growth over the forecast period.
Press Release Available @ https://www.reportsanddata.com/press-release/global-epinephrine-market
Explore More Industry Research by Reports and Data:
Small Lymphocytic Lymphoma Treatment Market @ https://www.biospace.com/article/small-lymphocytic-lymphoma-treatment-market-growth-drivers-analysis-and-business-trends-insights-to-2030-reports-and-data/
Thrombocytopenia Market @ https://www.biospace.com/article/thrombocytopenia-market-detail-analysis-by-share-types-applications-and-future-growth-till-2030-reports-and-data/
Hydrocephalus Treatment Market @ https://www.biospace.com/article/hydrocephalus-treatment-market-report-analysis-growth-trends-and-top-key-players-by-2030-reports-and-data/
Diffuse Large B-Cell Lymphoma (DLBCL) Treatment Market @ https://www.biospace.com/article/diffuse-large-b-cell-lymphoma-dlbcl-treatment-market-to-register-phenomenal-growth-rate-by-2030-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video
